David O'Neill
37Patents
8h-index
47Co-inventors
75Inventor score
Filing activity: Mar 18, 1982 → Jun 13, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7748047B2 | Preventing fraudulent internet account access | Electricity | 15 | Active |
| US7125878B2 | Substituted pyrroline kinase inhibitors | Human Necessities | 14 | Expired |
| US7624923B2 | Providing directed content to anonymous customers | Physics | 13 | Expired |
| US7975917B2 | Providing directed content to anonymous customers | Physics | 12 | Active |
| US4416484A | Flat bed side assembly | Performing Operations; Transporting | 9 | Expired |
| US10752644B2 | Modulators of Sestrin-GATOR2 interaction and uses thereof | Chemistry; Metallurgy | 8 | Active |
| US10414782B2 | Modulators of sestrin-GATOR2 interaction and uses thereof | Chemistry; Metallurgy | 8 | Active |
| US10100066B2 | Modulators of sestrin-GATOR2 interaction and uses thereof | Chemistry; Metallurgy | 8 | Active |
| US10683308B2 | Rapamycin analogs and uses thereof | Chemistry; Metallurgy | 7 | Active |
| US8255158B2 | Travel route adjustment | Physics | 6 | Active |
| US11325924B2 | Modulators of Sestrin-GATOR2 interaction and uses thereof | Chemistry; Metallurgy | 5 | Active |
| US8297330B2 | Welded knot end effector | Performing Operations; Transporting | 4 | Active |
| US10644962B2 | Continuous monitoring for performance evaluation of service interfaces | Electricity | 4 | Active |
| US7524858B2 | Substituted pyrroline kinase inhibitors | Human Necessities | 3 | Expired |
| US7978830B2 | Broadcasting voicemail replies | Electricity | 3 | Active |
| US8709183B2 | Welded knot end effector | Performing Operations; Transporting | 3 | Active |
| US10980784B2 | Rapamycin analogs and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US8069479B2 | Position and velocity-based mobile device management | Electricity | 2 | Active |
| US5397210A | Safety block | Performing Operations; Transporting | 1 | Expired |
| US7705015B2 | Substituted pyrroline kinase inhibitors | Human Necessities | 1 | Active |
| US7786135B2 | Substituted pyrroline kinase inhibitors | Human Necessities | 1 | Active |
| US7781450B2 | Substituted pyrroline kinase inhibitors | Human Necessities | 1 | Active |
| US10414727B2 | Phenyl amino piperidine mTORC inhibitors and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US7601722B2 | Aryl sulfamide derivatives and methods of their use | Chemistry; Metallurgy | 1 | Active |
| US9410205B2 | Methods for predicting survival in metastatic melanoma patients | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.